Key Publications from EUROASPIRE IV and V

A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries.
Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology EUROASPIRE IV cross-sectional survey in fourteen European regions.
Lifestyles and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology EUROASPIRE V survey.
Primary prevention efforts are poorly developed in people at high cardiovascular risk. A report from the ESC-EORP EUROASPIRE V survey in 16 European countries.

All EUROASPIRE Publications

Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Dietary management of high-risk patients European Society of Cardiology EUROASPIRE V survey.
Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.
Gender differences in health-related quality of life and psychological distress among coronary patients: Does comorbidity matter? Results from the ESC EORP EUROASPIRE V registry.
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease.
Gender differences in cardiovascular risk factor awareness. Results from the ESC EORP EUROASPIRE V Registry.
Measures of insulin resistance as a screening tool for dysglycaemia in patients with coronary artery disease. A report from the EUROASPIRE V population.
Gender differences in lifestyle management among coronary patients and the association with education and age. Results from the ESC EORP EUROASPIRE V Registry.
Assessing the probability of risk factor control in patients with coronary heart disease based on individual and large-area residential characteristics: results from the ESC-EORP EUROASPIRE V survey.
Gender differences in cardiovascular risk factor awareness. Results from the ESC EORP EUROASPIRE V Registry.
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys.
Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model. Results from a prospective study in 27 countries in the WHO European region - The EURObservational Research Programme (EORP) of the European Society of Cardiology (ESC).
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry.
Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test. Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC‑EORP EUROASPIRE surveys.
Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile.
Medical treatment in coronary patients: Is there still a gender gap? Results from European Society of Cardiology EUROASPIRE V Registry.
Functional versus morphological assessment of vascular age in patients with coronary heart disease.
Alcohol consumption patterns across Europe and adherence to the European guidelines in coronary patients: Findings from the ESC-EORP EUROASPIRE V survey.
Peripheral arterial disease and intermittent claudication in coronary heart disease patients.
Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V.
Screening for glucose perturbations and risk factor management in dysglycaemic patients with coronary artery disease - a persistent challenge in need of substantial improvement A report from EUROASPIRE V.
Percentage LDL-C response to a given statin dose is not fixed across the pre-treatment range: real world evidence from clinical practice. Data from the ESC-EORP EUROASPIRE V Study.
EQ-5D in coronary patients: what are they suffering from? Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.
Management of dyslipidaemia in patients with coronary hert disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.
Return to work and associations with psychosocial well-being and health-related quality of life in coronary heart disease patients: Results from EUROASPIRE IV.
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.
Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.
Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the EuropeanSociety of Cardiology.
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients—Insights from the German Subset of the EUROASPIRE IV Survey.
Patient’s and physician’s awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey.
The prognostic value of fasting plasma glucose, two-hour post load glucose, and HbA1c in patients with coronary artery disease: a report from EUROASPIRE IV.
The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention.
Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey.
Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation – Results from the German EuroAspire IV cohort.
Time trends in lifestyle, risk factor control and use of cardioprotective drug therapies in patients with coronary heart disease in Europe: results from three EUROASPIRE surveys, 1999 – 2013, of the European Society of Cardiology.
Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.
Physical activity status in patients with coronary heart disease: results from the cross-sectional EUROASPIRE surveys.
The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.
Lifestyle and risk factor management in people at high cardiovascular risk: comparison between the EUROASPIRE III and IV primary care surveys of the European Society of Cardiology.
Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – findings from the EUROASPIRE IV survey.
The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology.
Adverse lifestyle trends counter improvements in cardiovascular risk factor management in coronary patients: results from three EUROASPIRE cross sectional surveys 1999 – 2013 of the European Society of Cardiology.
Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology.
EURObservational Research Programme: EUROASPIRE survey of cardiovascular prevention and diabetes in 24 countries in Europe.
Patients with coronary heart disease and diabetes need improved management. A report from EUROASPIRE IV.
Screening for dysglycemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test and HbA1c. A report from EUROASPIRE IV.
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfill guideline recommended targets?
Self-reported health status in coronary heart disease patients: a comparison with the general population.
Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.
Passive smoking and smoking cessation among patients with coronary heart disease across Europe: Results from the EUROASPIRE III survey.
The association between self-reported Lifestyle changes on and health-related quality of life in coronary patients: the EUROASPIRE III survey.
Risk factor awareness in a coronary population and the association with health-related quality of life outcomes.
Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey.
Health related quality of life in coronary patients and Its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey.
Residual risk of cardiovascular mortality in patients with coronary heart disease: The EUROASPIRE Risk Categories.
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey.
Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients.
Determinants of risk factor control in subjects with coronary heart disease: a report from the EUROASPIRE III investigators.
Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study.
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project.
Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: Results from the EUROASPIRE III Study.
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high risk subjects in general practice: cross-sectional survey in 12 European countries.
Management of overweight and obese patients with coronary heart disease in Europe.
Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
Cardiovascular prevention guidelines - the clinical reality: a comparison of EUROASPIRE I, II and III surveys in 8 European countries.
EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries.
Treatment Potential for Cholesterol Management in Patients with Coronary Heart Disease in 15 European Countries: Findings from the EUROASPIRE II Survey.
Smoking behaviour in European patients with established coronary heart disease.
Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from the EUROASPIRE II survey.
Overweight and obesity in patients with established coronary heart disease: Are we meeting the challenge?
Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy.
Screening of family members of patients with premature coronary disease. Results from the EUROASPIRE II family survey.
Blood pressure is insufficiently controlled in European patients with established coronary heart disease.
Lifestyle and risk factor management and use of drug therapies in coronary patients from fifteen countries. Principal results from EUROASPIRE II.
Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort.
Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries.
EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results.